Vivek Venugopal
Orthopaedic Surgery · Keene, NHNPI 1992183917
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (35.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Smith+Nephew at 52.7% of the total.
Across 58 payments — averaging $306.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$9K
- Medical Device Business Services, Inc.$4K
- Stryker$3K
- Encore Medical, LP$2K
- Zimmer Biomet$255
- Wishbone Medical Inc.$150
- plus $26 from 1 others
What the payments were for
- Consulting fees$3,56320%
- Speaking & faculty fees$1,5008%
- Travel & lodging$3,06817%
- Food & beverage$3,29319%
- Education$6,37536%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 12 | $9,373 |
| Medical Device Business Services, Inc. | 4 | $3,760 |
| Stryker | 37 | $2,732 |
| Encore Medical, LP | 1 | $1,500 |
| Zimmer Biomet | 2 | $255 |
| Wishbone Medical Inc. | 1 | $150 |
| Trimed, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$3,314
- DJO SURGICAL$3,000
- OR3O Dual Mobility$1,654
- Legion Revision$1,553
- RI.HIP NAVIGATION$1,553
- JOURNEY$1,553
- MAKO$1,366
- EVOS$217
- TRIATHLON$168
- Velys$156
- Affixus$137
- Persona$118
- REDAPT$102
How this compares
$17,798 in reported general payments places this provider in the 80th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 422 | $1,027 |
| Celecoxib | 25 | $408 |
| Oxycodone Hcl | 25 | $166 |
| Methylprednisolone | 13 | $61 |
| Hydromorphone Hcl | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Keene
- Charles QinKeene$46K
- Mia QinKeene$22K
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- John-Erik BellLebanon$528K
- Michael MorwoodPortsmouth$506K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
- David RichardsNashua$122K
- Philip WolinskyLebanon$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.